Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

PDZ and LIM domain protein 1(PDLIM1)/CLP36 promotes breast cancer cell migration, invasion and metastasis through interaction with α-actinin

Oncogene volume 34, pages 1300–1311 (2015)Cite this article

Subjects

Abstract

Increased CLP36 expression has been found to be closely associated with breast cancer progression. However, whether and how it contributes to malignant behavior of breast cancer cells were not known. We show here that CLP36 is critical for promoting breast cancer cell migration and invasion in vitro and metastasis in vivo, whereas it is dispensable for breast cell proliferation and anchorage-independent growth in vitro and tumor growth in vivo. CLP36 interacted with both α-actinin-1 and -4 in breast cancer cells. Depletion of either α-actinin-1 or -4 inhibited breast cancer cell migration. Furthermore, mutations inhibiting the α-actinin-binding activity abolished the ability of CLP36 to promote breast cancer cell migration. Finally, depletion of CLP36 or disruption of the CLP36–α-actinin complex in breast cancer cells substantially inhibited Cdc42 activation, cell polarization and migration. Our results identify CLP36 as an important regulator of breast cancer cell migration and metastasis, and shed light on how increased CLP36 expression contributes to the progression of breast cancer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10

Similar content being viewed by others

References

  1. Cardiff RD, Anver MR, Gusterson BA, Hennighausen L, Jensen RA, Merino MJ et al. The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene 2000; 19: 968–988.

    Article  CAS  PubMed  Google Scholar 

  2. Pitteri SJ, Kelly-Spratt KS, Gurley KE, Kennedy J, Buson TB, Chin A et al. Tumor microenvironment-derived proteins dominate the plasma proteome response during breast cancer induction and progression. Cancer Res 2011; 71: 5090–5100.

    Article  CAS  PubMed  Google Scholar 

  3. Kotaka M, Ngai SM, Garcia-Barcelo M, Tsui SK, Fung KP, Lee CY et al. Characterization of the human 36-kDa carboxyl terminal LIM domain protein (hCLIM1). J Cell Biochem 1999; 72: 279–285.

    Article  CAS  PubMed  Google Scholar 

  4. Bauer K, Kratzer M, Otte M, de Quintana KL, Hagmann J, Arnold GJ et al. Human CLP36, a PDZ-domain and LIM-domain protein, binds to alpha-actinin-1 and associates with actin filaments and stress fibers in activated platelets and endothelial cells. Blood 2000; 96: 4236–4245.

    CAS  PubMed  Google Scholar 

  5. Vallenius T, Luukko K, Makela TP . CLP-36 PDZ-LIM protein associates with nonmuscle alpha-actinin-1 and alpha-actinin-4. J Biol Chem 2000; 275: 11100–11105.

    Article  CAS  PubMed  Google Scholar 

  6. Kotaka M, Kostin S, Ngai S, Chan K, Lau Y, Lee SM et al. Interaction of hCLIM1, an enigma family protein, with alpha-actinin 2. J Cell Biochem 2000; 78: 558–565.

    Article  CAS  PubMed  Google Scholar 

  7. Vallenius T, Scharm B, Vesikansa A, Luukko K, Schafer R, Makela TP . The PDZ-LIM protein RIL modulates actin stress fiber turnover and enhances the association of alpha-actinin with F-actin. Exp Cell Res 2004; 293: 117–128.

    Article  CAS  PubMed  Google Scholar 

  8. Tamura N, Ohno K, Katayama T, Kanayama N, Sato K . The PDZ-LIM protein CLP36 is required for actin stress fiber formation and focal adhesion assembly in BeWo cells. Biochem Biophys Res Commun 2007; 364: 589–594.

    Article  CAS  PubMed  Google Scholar 

  9. Liu Z, Blattner SM, Tu Y, Tisherman R, Wang JH, Rastaldi MP et al. Alpha-actinin-4 and CLP36 protein deficiencies contribute to podocyte defects in multiple human glomerulopathies. J Biol Chem 2011; 286: 30795–30805.

    Article  CAS  PubMed  Google Scholar 

  10. Miyazaki K, Ohno K, Tamura N, Sasaki T, Sato K . CLP36 and RIL recruit alpha-actinin-1 to stress fibers and differentially regulate stress fiber dynamics in F2408 fibroblasts. Exp Cell Res 2012; 318: 1716–1725.

    Article  CAS  PubMed  Google Scholar 

  11. Honda K, Yamada T, Endo R, Ino Y, Gotoh M, Tsuda H et al. Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion. J Cell Biol 1998; 140: 1383–1393.

    Article  CAS  PubMed  Google Scholar 

  12. Quick Q, Skalli O . Alpha-actinin 1 and alpha-actinin 4: contrasting roles in the survival, motility, and RhoA signaling of astrocytoma cells. Exp Cell Res 2010; 316: 1137–1147.

    Article  CAS  PubMed  Google Scholar 

  13. Honda K, Yamada T, Hayashida Y, Idogawa M, Sato S, Hasegawa F et al. Actinin-4 increases cell motility and promotes lymph node metastasis of colorectal cancer. Gastroenterology 2005; 128: 51–62.

    Article  CAS  PubMed  Google Scholar 

  14. Kikuchi S, Honda K, Tsuda H, Hiraoka N, Imoto I, Kosuge T et al. Expression and gene amplification of actinin-4 in invasive ductal carcinoma of the pancreas. Clin Cancer Res 2008; 14: 5348–5356.

    Article  CAS  PubMed  Google Scholar 

  15. Yamamoto S, Tsuda H, Honda K, Onozato K, Takano M, Tamai S et al. Actinin-4 gene amplification in ovarian cancer: a candidate oncogene associated with poor patient prognosis and tumor chemoresistance. Mod Pathol 2009; 22: 499–507.

    Article  CAS  PubMed  Google Scholar 

  16. Shao H, Wang JH, Pollak MR, Wells A . alpha-actinin-4 is essential for maintaining the spreading, motility and contractility of fibroblasts. PLoS One 2010; 5: e13921.

    Article  PubMed  Google Scholar 

  17. Te Velthuis AJ, Isogai T, Gerrits L, Bagowski CP . Insights into the molecular evolution of the PDZ/LIM family and identification of a novel conserved protein motif. PLoS One 2007; 2: e189.

    Article  PubMed  Google Scholar 

  18. Klaavuniemi T, Kelloniemi A, Ylanne J . The ZASP-like motif in actinin-associated LIM protein is required for interaction with the alpha-actinin rod and for targeting to the muscle Z-line. J Biol Chem 2004; 279: 26402–26410.

    Article  CAS  PubMed  Google Scholar 

  19. Etienne-Manneville S . Cdc42—the centre of polarity. J Cell Sci 2004; 117: 1291–1300.

    Article  CAS  PubMed  Google Scholar 

  20. Fritz G, Brachetti C, Bahlmann F, Schmidt M, Kaina B . Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters. Br J Cancer 2002; 87: 635–644.

    Article  CAS  PubMed  Google Scholar 

  21. Fritz G, Just I, Kaina B . Rho GTPases are over-expressed in human tumors. Int J Cancer 1999; 81: 682–687.

    Article  CAS  PubMed  Google Scholar 

  22. Johnson E, Seachrist DD, DeLeon-Rodriguez CM, Lozada KL, Miedler J, Abdul-Karim FW et al. HER2/ErbB2-induced breast cancer cell migration and invasion require p120 catenin activation of Rac1 and Cdc42. J Biol Chem 2010; 285: 29491–29501.

    Article  CAS  PubMed  Google Scholar 

  23. Yamaguchi H, Lorenz M, Kempiak S, Sarmiento C, Coniglio S, Symons M et al. Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and cofilin. J Cell Biol 2005; 168: 441–452.

    Article  CAS  PubMed  Google Scholar 

  24. Pichot CS, Arvanitis C, Hartig SM, Jensen SA, Bechill J, Marzouk S et al. Cdc42-interacting protein 4 promotes breast cancer cell invasion and formation of invadopodia through activation of N-WASp. Cancer Res 2010; 70: 8347–8356.

    Article  CAS  PubMed  Google Scholar 

  25. Bouzahzah B, Albanese C, Ahmed F, Pixley F, Lisanti MP, Segall JD et al. Rho family GTPases regulate mammary epithelium cell growth and metastasis through distinguishable pathways. Mol Med 2001; 7: 816–830.

    Article  CAS  PubMed  Google Scholar 

  26. Tu Y, Huang Y, Zhang Y, Hua Y, Wu C . A new focal adhesion protein that interacts with integrin-linked kinase and regulates cell adhesion and spreading. J Cell Biol 2001; 153: 585–598.

    Article  CAS  PubMed  Google Scholar 

  27. Tu Y, Wu S, Shi X, Chen K, Wu C . Migfilin and mig-2 link focal adhesions to filamin and the actin cytoskeleton and function in cell shape modulation. Cell 2003; 113: 37–47.

    Article  CAS  PubMed  Google Scholar 

  28. Shi X, Wu C . A suppressive role of mitogen inducible gene-2 in mesenchymal cancer cell invasion. Mol Cancer Res 2008; 6: 715–724.

    Article  CAS  PubMed  Google Scholar 

  29. Zhang Y, Tu Y, Gkretsi V, Wu C . Migfilin interacts with vasodilator-stimulated phosphoprotein (VASP) and regulates VASP localization to cell-matrix adhesions and migration. J Biol Chem 2006; 281: 12397–12407.

    Article  CAS  PubMed  Google Scholar 

  30. Uehara N, Matsuoka Y, Tsubura A . Mesothelin promotes anchorage-independent growth and prevents anoikis via extracellular signal-regulated kinase signaling pathway in human breast cancer cells. Mol Cancer Res 2008; 6: 186–193.

    Article  CAS  PubMed  Google Scholar 

  31. Shi X, Ma YQ, Tu Y, Chen K, Wu S, Fukuda K et al. The MIG-2/integrin interaction strengthens cell-matrix adhesion and modulates cell motility. J Biol Chem 2007; 282: 20455–20466.

    Article  CAS  PubMed  Google Scholar 

  32. Nobes CD, Hall A . Rho GTPases control polarity, protrusion, and adhesion during cell movement. J Cell Biol 1999; 144: 1235–1244.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by NIH Grant GM65188 to CW.

Author information

Authors and Affiliations

  1. Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

    Z Liu, Y Tu, K Chen & C Wu

  2. State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China

    Y Zhan & Z Liu

  3. University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA

    C Wu

Authors
  1. Z Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Y Zhan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Y Tu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Z Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C Wu.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, Z., Zhan, Y., Tu, Y. et al. PDZ and LIM domain protein 1(PDLIM1)/CLP36 promotes breast cancer cell migration, invasion and metastasis through interaction with α-actinin. Oncogene 34, 1300–1311 (2015). https://doi.org/10.1038/onc.2014.64

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2014.64

This article is cited by

Search

Advanced search

Quick links